TransMedics (TMDX) Gross Margin (2018 - 2026)

TransMedics' Gross Margin history runs 9 years deep, the most recent figure standing at 58.16% for Q1 2026.

• On a quarterly basis, Gross Margin fell 331.0% year-over-year to 58.16% in Q1 2026; TTM through Mar 2026 was 59.09%, a 38.0% decrease from a year earlier, with the FY2025 full-year figure at 59.92%, up 56.0% from the prior year.
• Gross Margin steadied at 58.16% in Q1 2026 per TMDX's latest filing, from 58.11% in the prior quarter.
• Across five years, Gross Margin topped out at 76.22% in Q1 2022 and bottomed at 55.94% in Q3 2024.
• The 5-year median for Gross Margin is 61.38% (2025), against an average of 63.4%.
• Biggest YoY gain for Gross Margin was 1323 bps in 2022; the steepest drop was 1577 bps in 2022.
• Year by year, Gross Margin stood at 65.99% in 2022, then fell by 11 bps to 59.04% in 2023, then grew by 0 bps to 59.21% in 2024, then decreased by 2 bps to 58.11% in 2025, then climbed by 0 bps to 58.16% in 2026.
• Per Business Quant, the three latest TMDX Gross Margin figures stand at 58.16% (Q1 2026), 58.11% (Q4 2025), and 58.8% (Q3 2025).